This was my experience working in SynBio -- the iteration cycles are so much longer, the failures so much more complex, that someone who comes from a software-f

This was my experience working in SynBio -- the iteration cycles are so much longer, the failures so much more complex, that someone who comes from a software-first background has a hard time because it just doesn't scale as nicely. If we look at the space, I think it is clear that biologist first companies have been the clear winners up to this point -- Gingko Bioworks being one clear example